Immix Biopharma Inc. (NASDAQ: IMMX) Stock Information | RedChip

Immix Biopharma Inc. (NASDAQ: IMMX) Listen to this Section


$1.90
+0.0050 ( +0.27% ) 78.2K

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Market Data


Open


$1.90

Previous close


$1.89

Volume


78.2K

Market cap


$52.16M

Day range


$1.83 - $1.92

52 week range


$1.55 - $7.75

Insider Ownership Transactions

Total Amount Purchased: -505,000.00 | $ -956,975.00

Date Type Amount Purchased Purchaser
2023-09-05 Buy 1000.00 Marquet Magda
2023-08-23 Sale -20000.00 Chudnovsky Yekaterina
2023-08-14 Sale -193000.00 Morris Gabriel S
2023-08-14 Sale -20000.00 BUCHAN MELISSA JANE
2023-08-14 Sale -20000.00 Hsu Jason
2023-08-14 Sale -20000.00 Ng Carey
2023-08-14 Sale -20000.00 Adams Helen C.
2023-08-14 Sale -193000.00 Rachman Ilya M
2023-08-14 Sale -20000.00 Marquet Magda

SEC Fillings


Form Type Description Pages Date
10-k Annual reports 78 Mar 29, 2024
8-k 8K-related 19 Feb 06, 2024
8-k 8K-related 14 Feb 05, 2024
4 Insider transactions 1 Dec 12, 2023
10-q Quarterly Reports 54 Nov 13, 2023
4/a Other 1 Nov 09, 2023
4/a Other 1 Nov 09, 2023
4 Insider transactions 1 Sep 18, 2023
4 Insider transactions 1 Sep 15, 2023
4 Insider transactions 1 Sep 14, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.